Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGunsynd Regulatory News (GUN)

Share Price Information for Gunsynd (GUN)

Share Price is delayed by 15 minutes
Get Live Data
0.11    0.0025 (2.33%)
Bid:
0.10
Ask:
0.12
Spread: 0.02 (20.00%)
Market Cap: £1.62m
GUN Live PriceLast checked at - London Stock Exchange

Intraday Gunsynd Share Chart

Eagle Mountain Mining Update

19 May 2021 10:45

RNS Number : 1498Z
Gunsynd PLC
19 May 2021
 

 

Gunsynd plc

 

("Gunsynd" or the "Company")

 

 

Report from Copper Skarn Expert on Further Prospective Mineralisation

at Oracle Ridge - Eagle Mountain Mining

 

 

Gunsynd Plc (AIM: GUN, AQSE: GUN) is pleased to announce an update from Eagle Mountain Mining Limited ("Eagle Mountain"), one of Gunsynd's investee companies, an ASX listed copper-gold exploration and development company (ASX: EM2).

 

Eagle Mountain has recently received an initial technical report from Dr Larry Meinert, a world-renowned expert on skarns and associated mineralisation who was engaged earlier in 2021 to provide support to Eagle Mountain's technical team.

 

Dr Meinert's review included examination of drill core, mapping of underground formations and assay analysis.

Key conclusions from Dr Meinert's report include:

• The southern extension to the Oracle Ridge mine area is prospective for additional copper-rich mineralisation

• Potential for additional skarn-hosted mineralisation exists in the central and southern part of the Oracle Ridge mine area beneath the Leatherwood intrusive and forms a prime target for deeper drilling

• Aeromagnetics is an effective tool in targeting copper mineralisation at Oracle Ridge

• Detailed logging of minerals across the deposit will allow vectoring towards copper-rich zones

 

Dr Meinert will continue to collaborate with Eagle Mountain's technical team to further improve the knowledge of the mineralisation system, evaluate exploration results at near mine targets including OREX, and define new prospective areas in the Oracle Ridge region.

 

Implications for Drilling Programme 

The outcomes of Dr Meinert's work support the Eagle Mountain's decision to prioritise exploration drilling at the Oracle Ridge mine in the southern zone. Several pads have been recently established and roads refurbished to facilitate better access to this area in the coming months. The drill rig has recently moved from the eastern side of Marble Mountain and is currently drilling from one of these new pads. A drone-supported magnetic survey has been recently completed at OREX and the data is currently being interpreted. Results of the survey will be used to prioritise drill targets in this area.

 

Peter Ruse, a Director of Gunsynd, commented: "Gunsynd continues to be impressed by the excellent exploration and resource delineation being delivered by the team at Eagle Mountain. The report received from Dr. Meinhart is significant in a number areas, highlighting the strong potential for further high grade potential beneath the existing resource, the southern extension to the existing resource and a 750m magnetic anomaly coinciding with the historical exploration success. This information is pleasing amongst a backdrop of incredibly strong copper prices that have seen the commodity rallying to the highest levels since the last super cycle a decade ago, benefitting from a recovering global economy and the clean-energy transformation."

 

About Dr Larry Meinert 

Dr Meinert, of Meinert Consulting based in Washington DC USA, is currently:

Editor in Chief - Economic Geology

Affiliate Research Professor, Colorado School of Mines, Golden CO USA

Previously, Dr Meinert was:

Deputy Associate Director - Energy and Mineral Resources at the U.S. Geological Survey

Congressional Fellow in both the U.S. Senate and House of Representatives

Professor at Smith College, Massachusetts USA

Professor - Economic Geology at Washington State University, Washington USA

 

About Eagle Mountain Mining Limited

 

Eagle Mountain Mining Limited (ASX: EM2), established in 2017, is a copper-gold explorer focused on the strategic exploration and development of advanced and greenfield projects in Arizona.

 

Arizona is at the heart of America's mining industry and home to some of the world's largest copper discoveries, now owned by major mining companies including BHP, Rio Tinto, Freeport McMoRan and Hudbay. Eagle Mountain's Oracle Ridge and Silver Mountain Projects are within the Laramide Arc which hosts many of these significant copper porphyry deposits.

 

Oracle Ridge is a high grade, advanced stage underground copper/gold/silver project. The project includes an NI43-101 resource of 11.7mt at 1.57%Cu, 17.47g/t Ag and 0.18g/t Au. Eagle Mountain believes there is significant potential to expand the known resources through additional drilling, along with exploration at depth to define the source of the mineralisation.

 

The Directors of Gunsynd accept responsibility for this announcement.

 

For further information please contact:

 

Gunsynd plc

Hamish Harris/ Peter Ruse

 

 

+44 (0) 78 7958 4153

Cairn Financial Advisers LLP

James Caithie / Liam Murray / Mark Rogers

 

+44 (0) 20 7213 0880

 

Peterhouse Capital Limited

Lucy Williams

 

+44 (0) 20 7469 0936

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UPDEANSNFLDFEEA
Date   Source Headline
8th Jul 20117:00 amRNSChange of Registered Office
21st Jun 201111:00 amRNSDirectorate Change
23rd May 201111:45 amRNSResult of General Meeting
11th May 201111:17 amRNSDirector's Dealing
6th May 20117:00 amRNSAcquisition and Placing to raise £2 million
27th Apr 20112:30 pmRNSBusiness Update
8th Mar 20117:00 amRNSInterim Results
2nd Mar 20113:12 pmRNSHolding(s) in Company
25th Feb 20117:00 amRNSHolding(s) in Company
20th Jan 20111:23 pmRNSResult of AGM
17th Jan 20117:00 amRNSSyntopix to research biofilms for Beiersdorf AG
14th Jan 201110:13 amRNSPosting of Annual Report and notice of AGM
3rd Dec 20107:00 amRNSGrant of share options to Directors
29th Nov 20107:00 amRNSFinal Results
11th Nov 20107:00 amRNSAppointment of Broker
1st Nov 20107:00 amRNSSecond Agreement with Sinclair Pharma
29th Sep 20105:05 pmRNSHolding(s) in Company
27th Sep 20102:51 pmRNSHolding(s) in Company
23rd Aug 20107:00 amRNSAgreement with Global Consumer Products Company
22nd Jun 20103:20 pmRNSDirectorate Change
22nd Apr 20107:00 amRNSAgreement with Sinclair Pharma plc
31st Mar 201011:25 amRNSResult of General Meeting
15th Mar 201011:08 amRNSProposed Fundraising
12th Mar 20107:00 amRNSInterim Results
3rd Feb 20107:00 amRNSDirectorate Change
2nd Feb 20102:30 pmRNSResult of AGM
7th Jan 20107:00 amRNSPreliminary results
12th Nov 20097:00 amRNSBusiness Update
12th Nov 20097:00 amRNSClinical results from Phase II cosmetic study
28th Apr 20097:00 amRNSHalf Yearly Report
14th Apr 20097:00 amRNSRe Contract
3rd Nov 20087:00 amRNSFinal Results
25th Sep 20087:00 amRNSChange of Adviser
29th Aug 20087:00 amRNSTotal Voting Rights
12th Aug 200811:58 amRNSHolding(s) in Company
6th Aug 20081:13 pmRNSResult of EGM & Director's In
15th Jul 20087:00 amRNSProposed fundraising
3rd Jul 20087:00 amRNSProctor & Gamble Agreement
24th Apr 20087:00 amRNSInterim Results
25th Feb 20087:00 amRNSPositive Trial Results
4th Feb 200810:51 amRNSHolding(s) in Company
21st Dec 20072:50 pmRNSOral Healthcare Agreement
15th Nov 20074:03 pmRNSAnnual Report and Accounts
18th Oct 20077:01 amRNSPreliminary Results
16th Aug 20077:00 amRNSPhase I Results
13th Jun 20077:01 amRNSPhase I Acne Trial Starts
8th May 20077:02 amRNSCRO Appointment
30th Apr 20079:00 amRNSTotal Voting Rights
25th Apr 200710:45 amRNSDirector/PDMR Shareholding
24th Apr 20074:12 pmRNSAdditional Listing

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.